dacarbazine has been researched along with chitosan in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benoit, JP; Boesen, K; Lagarce, F; Messaoudi, K; Saulnier, P | 1 |
| Di Martino, A; Sedlarik, V | 1 |
| Benoit, JP; Danhier, F; Lagarce, F; Lemaire, L; Messaoudi, K | 1 |
| Fan, L; He, J; Qiao, Y; Tan, J; Wang, Q; Wu, H; Yang, Q; Zhang, Y | 1 |
| Budriene, S; Di Martino, A; Maciulyte, S; Pavelkova, A; Sedlarik, V | 1 |
| Haririan, I; Irani, M; Mir Mohamad Sadeghi, G | 1 |
| Gupta, L; Gupta, U; Nakhate, KT; Qayum, A; Sahu, H; Sharma, AK; Singh, SK | 1 |
| He, J; Huang, X; Sun, K; Teng, W; Tian, J; Yang, J; Zhan, X; Zhou, C; Zhou, L | 1 |
| Azambuja, JH; Braganhol, E; de Cássia Sant'ana, R; de Souza, PO; Debom, GN; Fachel, FNS; Gelsleichter, NE; Lenz, GS; Michels, LR; Roliano, GG; Teixeira, FC; Teixeira, HF; Visioli, F | 1 |
| Ataabadi, FV; Etebari, M; Oveissi, F; Taheri, A | 1 |
10 other study(ies) available for dacarbazine and chitosan
| Article | Year |
|---|---|
Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide.
Topics: Acylation; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Chitosan; Dacarbazine; Drug Synergism; ErbB Receptors; Gene Silencing; Glioblastoma; Humans; Lipids; Nanocapsules; Particle Size; RNA, Small Interfering; Temozolomide; Treatment Outcome | 2014 |
Amphiphilic chitosan-grafted-functionalized polylactic acid based nanoparticles as a delivery system for doxorubicin and temozolomide co-therapy.
Topics: Chitosan; Dacarbazine; Doxorubicin; Drug Delivery Systems; Humans; Lactic Acid; Male; Molecular Structure; Nanoparticles; Particle Size; Polyesters; Polymers; Surface Properties; Surface-Active Agents; Temozolomide; Temperature | 2014 |
Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Chitosan; Dacarbazine; Drug Delivery Systems; Drug Resistance, Neoplasm; ErbB Receptors; Female; Galectin 1; Gene Silencing; Glioblastoma; Humans; Lipids; Mice, Nude; Nanocapsules; RNA, Small Interfering; Temozolomide; Tumor Burden | 2015 |
Dual loading miR-218 mimics and Temozolomide using AuCOOH@FA-CS drug delivery system: promising targeted anti-tumor drug delivery system with sequential release functions.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chitosan; Dacarbazine; Delayed-Action Preparations; Drug Delivery Systems; Fatty Acids; Female; Glioblastoma; Gold Compounds; Humans; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Nanogels; Polyethylene Glycols; Polyethyleneimine; Sulfhydryl Compounds; Temozolomide; Xenograft Model Antitumor Assays | 2015 |
Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide.
Topics: Alginates; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Chitosan; Dacarbazine; Delayed-Action Preparations; Drug Carriers; Drug Combinations; Drug Compounding; Drug Liberation; Drug Stability; Fluorouracil; Glucuronic Acid; Hexuronic Acids; Nanoparticles; Pectins; Prodrugs; Temozolomide | 2016 |
A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide.
Topics: Antineoplastic Agents; Biocompatible Materials; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Dacarbazine; Drug Carriers; Drug Liberation; Humans; Kinetics; Nanofibers; Nanoparticles; Polyesters; Polyurethanes; Temozolomide | 2017 |
Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide.
Topics: Animals; Antineoplastic Agents; Biological Transport; Blood-Brain Barrier; Brain; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Dacarbazine; Dendrimers; Drug Liberation; Drug Stability; Glioma; Half-Life; Humans; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Particle Size; Rats; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Temozolomide; Tissue Distribution | 2018 |
CD47-mediated DTIC-loaded chitosan oligosaccharide-grafted nGO for synergistic chemo-photothermal therapy against malignant melanoma.
Topics: CD47 Antigen; Cell Line, Tumor; Chitosan; Dacarbazine; Doxorubicin; Humans; Melanoma; Nanoparticles; Oligosaccharides; Phototherapy; Photothermal Therapy; Skin Neoplasms | 2021 |
Metastatic Melanoma: A Preclinical Model Standardization and Development of a Chitosan-Coated Nanoemulsion Containing Temozolomide to Treat Brain Metastasis.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chitosan; Dacarbazine; Humans; Melanoma; Mice; Temozolomide | 2023 |
Preparation of chitosan nanoparticles for simultaneous drug delivery of dacarbazine and enoxaparin in melanoma.
Topics: Chitosan; Dacarbazine; Drug Delivery Systems; Enoxaparin; Humans; Melanoma; Nanoparticles | 2023 |